Guangdong Hybribio Biotech Co.,Ltd. engages in the research and development, manufacture, and sale of nucleic acid molecular diagnostic products for hospitals and medical institutes. It provides in-vitro diagnostic kits for human papilloma virus, sexually transmitted diseases (STD), thalassemia, and prenatal and postnatal. The company also offers STD real time PCR kits; hepatitis B virus real-time PCR kits and thalassemia genoarray diagnostic kits; hearing loss susceptibility genoarray diagnostic kits; COVID-19 real-time PCR kits; and devices/instruments, including automated nucleic acid extraction, automatic medical PCR analysis, flow-through hybridization, auto DNA extraction, and fluorescent quantitative detection systems, as well as after-sales technical service support. Its products are used in the fields of national screening, clinical, and research purposes. The company operates in the Asia Pacific, the South East Asia, the Middle East, Europe, Africa, and South America. Guangdong Hybribio Biotech Co.,Ltd. was founded in 2003 and is based in Sheung Wan, Hong Kong.
Guangdong Hybribio Biotech Dividend Announcement
• Guangdong Hybribio Biotech announced a annually dividend of ¥0.07 per ordinary share which will be made payable on 2024-05-23. Ex dividend date: 2024-05-23
• Guangdong Hybribio Biotech annual dividend for 2024 was ¥0.07
• Guangdong Hybribio Biotech annual dividend for 2023 was ¥0.53
• Guangdong Hybribio Biotech's trailing twelve-month (TTM) dividend yield is 0.98%
• Guangdong Hybribio Biotech's payout ratio for the trailing twelve months (TTM) is -66.77%
• Guangdong Hybribio Biotech's dividend growth over the last five years (2018-2023) was 0.98% year
Guangdong Hybribio Biotech Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-05-23 | ¥0.07 | annually | 2024-05-23 |
2023-05-22 | ¥0.53 | annually | 2023-05-22 |
2022-04-29 | ¥0.53 | annually | 2022-04-29 |
2021-05-28 | ¥0.20 | annually | 2021-05-28 |
2020-05-21 | ¥0.16 | annually | 2020-05-21 |
2019-04-30 | ¥0.25 | annually | 2019-04-30 |
2018-05-09 | ¥0.50 | annually | 2018-05-09 |
Guangdong Hybribio Biotech Dividend per year
Guangdong Hybribio Biotech Dividend growth
Guangdong Hybribio Biotech Dividend Yield
Guangdong Hybribio Biotech current trailing twelve-month (TTM) dividend yield is 0.98%. Interested in purchasing Guangdong Hybribio Biotech stock? Use our calculator to estimate your expected dividend yield:
Guangdong Hybribio Biotech Financial Ratios
Guangdong Hybribio Biotech Dividend FAQ
Other factors to consider when evaluating Guangdong Hybribio Biotech as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Guangdong Hybribio Biotech stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Guangdong Hybribio Biotech's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Guangdong Hybribio Biotech publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Guangdong Hybribio Biotech distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Guangdong Hybribio Biotech are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Guangdong Hybribio Biotech sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Guangdong Hybribio Biotech distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Guangdong Hybribio Biotech declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Guangdong Hybribio Biotech's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Guangdong Hybribio Biotech's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.